Clinical Trials Sponsored by Fuda Cancer Hospital, Guangzhou

Total 618 results

Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Renal Tumors (IRE)

Renal Tumor

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms (IRE)

Hilus Pulmonary Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms (IRE)

Uterine Cervical Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder

Hepatic Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroportion for Unresectable Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency (IRE)

Lung Neoplasms Accompanied by Respiratory Function Insufficiency

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for HCC Targeting GPC3

CAR-T Cell Immunotherapy | GPC3 Positive Hepatocellular Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms (IRE)

Prostatic Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Lung Neoplasms
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Lung Carcinoma

Lung Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient

Lung Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

Liver Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms (IRE)

Gallbladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Rectal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms (IRE)

Esophageal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms (IRE)

Renal Pelvic and Ureteral Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Progress Free Survival (PFS) and Overall Survival (OS)

China
Fuda Cancer Hospital, Guangzhou

Completed

Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC

Locally Advanced Pancreatic Adenocarcinoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

Chimeric Antigen Receptor-Modified T Cells for Breast Cancer

Breast Cancer

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

GD2 Positive Glioma | CAR-T Cell Immunotherapy

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CD19-targeting CAR T Cells for B Cell Lymphoma

B Cell Lymphoma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient

Pancreatic Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma

Cervical Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Liver Cancer HepaSphere Combined With Cryosurgery

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

Completed

The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.

Neoplastic Cells, Circulating

China
Fuda Cancer Hospital, Guangzhou

No longer available

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms (IRE)

Head and Neck Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli (IRE)

Liver Cancer

China
Fuda Cancer Hospital, Guangzhou

Completed

Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function

Hepatic Carcinoma

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve) (IRE)

Lymph Node Metastases

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms (IRE)

Urinary Bladder Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms (IRE)

Laryngeal Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Extremities Neoplasms (IRE)

Extremities Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms (IRE)

Stomach Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients

CAR-T Cell Immunotherapy | EphA2 Positive Malignant Glioma

China
Fuda Cancer Hospital, Guangzhou

Withdrawn

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

CAR-T Cell Immunotherapy | Glioma of Brain
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Liver Cancer

Pain | Liver Neoplasms | Cancer Pain

China
Fuda Cancer Hospital, Guangzhou

Completed

PENS or TENS for Pain in Pancreatic Cancer

Pain | Pancreatic Cancer | Cancer Pain

China

3

Subscribe